NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leukos Biotech

Leukos Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://www.leukosbiotech.com/

Last Round

Debt

Oct 7, 2022

Total Funding Raised

$5.35M

Company Overview

Leukos Biotech is a biopharmaceutical company that develops innovative therapies and diagnostic tools for hematological malignancies and solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

leukemia researchleukemia stem cellsdrug discoveryoncology therapeuticshematological oncologybiotech spin-offpreclinical developmenttherapeutic candidatebiopharmadrug licensingsmall-molecule therapeuticsdiagnostic biomarkersin-silico screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leukos Biotech Comps

Public and private peers based on sector, stage, and business model.

Leukos Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Leukos Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 7, 2022
VC RoundDec 31, 2018
GrantMay 1, 2018
SeedSep 21, 2016
GrantJan 1, 2016

Key People

Founding team and executive leadership

Ruth Muñoz Risueño

Chief Scientific Officer and Co-founder

Founding Team

Luis Ruiz-Avila

Chief Executive Officer

Executive Team

Leukos Biotech Investors

Notable investors and investment history

Leukos Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leukos Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leukos Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range5
Year Founded2015
Last FundingOct 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.